<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36224705</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Long COVID following Omicron wave in Eastern India-A retrospective cohort study.</ArticleTitle><Pagination><StartPage>e28214</StartPage><MedlinePgn>e28214</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e28214</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.28214</ELocationID><Abstract><AbstractText>Long coronavirus disease (COVID) or postacute sequelae of coronavirus disease of 2019 (COVID-19) is widely reported but the data of long COVID after infection with the Omicron variant is limited. This study was conducted to estimate the incidence, characteristics of symptoms, and predictors of long COVID among COVID-19 patients diagnosed during the Omicron wave in Eastern India. The cohort of COVID-19 patients included were adults (&#x2265;18 years) diagnosed as&#xa0;severe acute respiratory syndrome coronavirus 2 positive with Reverse Transcription Polymerase Chain Reaction. After 28 days of diagnosis; participants were followed up with a telephonic interview to capture data on sociodemographic, clinical history, anthropometry, substance use, COVID-19 vaccination status, acute COVID-19 symptoms, and long COVID symptoms. The long COVID symptoms were self-reported by the participants. Logistic regression was used to determine the predictors of long COVID. The median follow-up of participants was 73 days (Interquartile range; 67-83). The final analysis had 524 participants' data; among them 8.2% (95% Confidence Interval [CI]: 6%-10.9%) self-reported long COVID symptoms. Fatigue (34.9%) was the most common reported symptom followed by cough (27.9%). In multivariable logistic regression only two predictors were statistically significant-number of acute COVID-19 symptoms&#x2009;&#x2265;&#x2009;five (Adjusted odds ratio (aOR)&#x2009;=&#x2009;2.95, 95% CI: 1.30-6.71) and past history of COVID-19 (aOR&#x2009;=&#x2009;2.66, 95% CI: 1.14-6.22). The proportion of self-reported long COVID is considerably low among COVID-19 patients diagnosed during the Omicron wave in Eastern India when compared with estimates during Delta wave in the same setting.</AbstractText><CopyrightInformation>&#xa9; 2022 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arjun</LastName><ForeName>M C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences Bhubaneswar, Bhubaneswar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Arvind K</ForeName><Initials>AK</Initials><Identifier Source="ORCID">0000-0001-7063-7435</Identifier><AffiliationInfo><Affiliation>Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences Bhubaneswar, Bhubaneswar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>Payel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences Bhubaneswar, Bhubaneswar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravichandran</LastName><ForeName>Mythry</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences Bhubaneswar, Bhubaneswar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandal</LastName><ForeName>Srijani</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences Bhubaneswar, Bhubaneswar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pal</LastName><ForeName>Debkumar</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences Bhubaneswar, Bhubaneswar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Kajal</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences Bhubaneswar, Bhubaneswar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gajjala</LastName><ForeName>Alekhya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences Bhubaneswar, Bhubaneswar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venkateshan</LastName><ForeName>Mahalingam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>College of Nursing, All India Institute of Medical Sciences Bhubaneswar, Bhubaneswar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mishra</LastName><ForeName>Baijayantimala</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Microbiology, All India Institute of Medical Sciences Bhubaneswar, Bhubaneswar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patro</LastName><ForeName>Binod K</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences Bhubaneswar, Bhubaneswar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohapatra</LastName><ForeName>Prasanta R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine and Critical Care, All India Institute of Medical Sciences Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subba</LastName><ForeName>Sonu H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences Bhubaneswar, Bhubaneswar, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Omicron</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">postacute COVID-19 syndrome</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>12</Day><Hour>23</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36224705</ArticleId><ArticleId IdType="pmc">PMC9874641</ArticleId><ArticleId IdType="doi">10.1002/jmv.28214</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Coronavirus disease (COVID&#x2010;19)
2022. https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease
</Citation></Reference><Reference><Citation>Overview | COVID&#x2010;19 rapid guideline: managing the long&#x2010;term effects of COVID&#x2010;19 | Guidance | NICE. Nice.org.uk.&#xa0;Accessed July 28, 2022. https://www.nice.org.uk/guidance/ng188
</Citation></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post&#x2010;COVID&#x2010;19 condition or long COVID: a meta&#x2010;analysis and systematic review. J Infect Dis. 2022;225(8)jiac136. 10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez&#x2010;Leon S, Wegman&#x2010;Ostrosky T, Perelman C, et al. More than 50 long&#x2010;term effects of COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Sci Rep. 2021;11(1):16144. 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>National comprehensive guidelines for management of postcovid sequelae. Mohfw.gov.in.&#xa0;Accessed July 27, 2022. https://www.mohfw.gov.in/pdf/NationalComprehensiveGuidelinesforManagementofPostCovidSequelae.pdf
</Citation></Reference><Reference><Citation>Arjun MC, Singh AK, Pal D, et al. Prevalence, characteristics, and predictors of Long COVID among diagnosed cases of COVID&#x2010;19. medRxiv. 2022. 10.1101/2022.01.04.21268536</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.04.21268536</ArticleId><ArticleId IdType="pmc">PMC9767341</ArticleId><ArticleId IdType="pubmed">36538532</ArticleId></ArticleIdList></Reference><Reference><Citation>Can &#x2018;long COVID&#x2019; infect you after Omicron? WHO answers. mint.&#xa0;Accessed July 12, 2022. https://www.livemint.com/science/health/can-long-covid-infect-you-after-omicron-who-on-symptoms-vaccination-and-the-variant-11644404550699.html
</Citation></Reference><Reference><Citation>Singhal T. The emergence of Omicron: challenging times are here again. Indian J Pediatr. 2022;89(5):490&#x2010;496. 10.1007/s12098-022-04077-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12098-022-04077-4</ArticleId><ArticleId IdType="pmc">PMC8756165</ArticleId><ArticleId IdType="pubmed">35025038</ArticleId></ArticleIdList></Reference><Reference><Citation>Raju MK, Vivian Thangaraj JW, Selvavinayagam TS, et al. Clinical profile of patients infected with suspected SARS&#x2010;CoV&#x2010;2 Omicron variant of concern, Tamil Nadu, India, December 2021&#x2013;January 2022. Indian J Med Res. 2022;155(1):165&#x2010;170. 10.4103/ijmr.ijmr_312_22</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijmr.ijmr_312_22</ArticleId><ArticleId IdType="pmc">PMC9552397</ArticleId><ArticleId IdType="pubmed">35417991</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdullah F, Myers J, Basu D, et al. Decreased severity of disease during the first global Omicron variant COVID&#x2010;19 outbreak in a large hospital in Tshwane, South Africa. Int J Infect Dis. 2022;116:38&#x2010;42. 10.1016/j.ijid.2021.12.357</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.12.357</ArticleId><ArticleId IdType="pmc">PMC8713416</ArticleId><ArticleId IdType="pubmed">34971823</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrenn JO, Pakala SB, Vestal G, et al. COVID&#x2010;19 severity from Omicron and Delta SARS&#x2010;CoV&#x2010;2 variants. Influenza Other Respir Viruses. 2022;16(5):832&#x2010;836. 10.1111/irv.12982</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12982</ArticleId><ArticleId IdType="pmc">PMC9111734</ArticleId><ArticleId IdType="pubmed">35415869</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigal A. Milder disease with Omicron: is it the virus or the pre&#x2010;existing immunity. Nat Rev Immunol. 2022;22(2):69&#x2010;71. 10.1038/s41577-022-00678-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00678-4</ArticleId><ArticleId IdType="pmc">PMC8767774</ArticleId><ArticleId IdType="pubmed">35046570</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvard experts on Omicron and long COVID. Harvard Gazette. Accessed July 30, 2022. https://news.harvard.edu/gazette/story/2022/02/harvard-experts-expect-new-wave-of-long-covid-cases/&#xa0;</Citation></Reference><Reference><Citation>Indian SARS&#x2010;CoV&#x2010;2 Genomics Consortium (INSACOG).&#xa0;Accessed September 20, 2022. https://research.nibmg.ac.in/insacog/
</Citation></Reference><Reference><Citation>Obesity and overweight. Who.int.&#xa0;Accessed July 4, 2022. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
</Citation></Reference><Reference><Citation>Global COVID&#x2010;19 Clinical Platform Case Report Form (CRF) for Post COVID condition (Post COVID&#x2010;19 CRF). Who.int.&#xa0;Accessed July 4 2022. https://www.who.int/publications/i/item/global-covid-19-clinical-platform-case-report-form&#x2010;(crf)&#x2010;for&#x2010;post&#x2010;covid&#x2010;conditions&#x2010;(post&#x2010;covid&#x2010;19&#x2010;crf&#x2010;).</Citation></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9):e005427. 10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Eggink D, Andeweg SP, Vennema H, et al. Increased risk of infection with SARS&#x2010;CoV&#x2010;2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022. Euro Surveill. 2022;27(4):2101196. 10.2807/1560-7917.ES.2022.27.4.2101196</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.4.2101196</ArticleId><ArticleId IdType="pmc">PMC8796294</ArticleId><ArticleId IdType="pubmed">35086609</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahin D, Tanacan A, Anuk AT, et al. Comparison of clinical features and perinatal outcomes between pre&#x2010;variant and post&#x2010;variant periods in pregnant women with SARS&#x2010;CoV&#x2010;2: analysis of 1935 cases. Arch Gynecol Obstet. 2022;305(3):1&#x2010;10. 10.1007/s00404-022-06493-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-022-06493-5</ArticleId><ArticleId IdType="pmc">PMC8901098</ArticleId><ArticleId IdType="pubmed">35257193</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn F, Bonander C, Moghaddassi M, et al. Risk of severe COVID&#x2010;19 from the Delta and oOmicron variants in relation to vaccination status, sex, age and comorbidities&#x2014;surveillance results from Southern Sweden, July 2021 to January 2022. Euro Surveill. 2022;27(9):2200121. 10.2807/1560-7917.ES.2022.27.9.2200121/</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.9.2200121/</ArticleId><ArticleId IdType="pmc">PMC8895467</ArticleId><ArticleId IdType="pubmed">35241215</ArticleId></ArticleIdList></Reference><Reference><Citation>Madhi SA, Kwatra G, Myers JE, et al. Population immunity and Covid&#x2010;19 severity with Omicron variant in South Africa. N Engl J Med. 2022;386(14):1314&#x2010;1326. 10.1056/NEJMoa2119658</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2119658</ArticleId><ArticleId IdType="pmc">PMC8908853</ArticleId><ArticleId IdType="pubmed">35196424</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS&#x2010;CoV&#x2010;2. Lancet. 2022;399(10343):2263&#x2010;2264. 10.1016/S0140-6736(22)00941-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, et al. Fatigue and cognitive impairment in Post&#x2010;COVID&#x2010;19 syndrome: a systematic review and meta&#x2010;analysis. Brain Behav Immun. 2022;101:93&#x2010;135. 10.1016/j.bbi.2021.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post&#x2010;COVID syndrome: a systematic review and meta&#x2010;analysis. EClinicalMedicine. 2021;36:100899. 10.1016/j.eclinm.2021.100899</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini &#xc2;M, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID&#x2010;19: a systematic review. Int J Clin Pract. 2021;75(10):e14357. 10.1111/ijcp.14357</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2010;631. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Donnell JS, Chappell KJ. Chronic SARS&#x2010;CoV&#x2010;2, a cause of post&#x2010;acute COVID&#x2010;19 sequelae (Long&#x2010;COVID). Front Microbiol. 2021;12:724654. 10.3389/fmicb.2021.724654</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.724654</ArticleId><ArticleId IdType="pmc">PMC8365243</ArticleId><ArticleId IdType="pubmed">34408742</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co&#x2010;occurrence, and evolution of long&#x2010;COVID features: a 6&#x2010;month retrospective cohort study of 273,618 survivors of COVID&#x2010;19. PLoS Med. 2021;18(9):e1003773. 10.1371/journal.pmed.1003773</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Vimercati L, De Maria L, Quarato M, et al. Association between long COVID and Overweight/Obesity. J Clin Med. 2021;10(18):4143. 10.3390/jcm10184143</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10184143</ArticleId><ArticleId IdType="pmc">PMC8469321</ArticleId><ArticleId IdType="pubmed">34575251</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post&#x2010;vaccination SARS&#x2010;CoV&#x2010;2 infection in UK users of the COVID symptom study app: a prospective, community&#x2010;based, nested, case&#x2010;control study. Lancet Infect Dis. 2022;22(1):43&#x2010;55. 10.1016/S1473-3099(21)00460-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>The effectiveness of vaccination against Long Covid: a rapid evidence briefing (February 2022). Patient Safety Learning&#x2014;the hub.&#xa0;Accessed July 27, 2022. https://www.pslhub.org/learn/coronavirus-covid19/data-and-statistics/the-effectiveness-of-vaccination-against-long-covid-a-rapid-evidence-briefing-february-2022-r6159/
</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>